
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1099 | 1023 | 1054 | 1438 | 1822 | 2195 |
Fund Return | 9.9% | 2.31% | 5.36% | 12.88% | 12.74% | 8.18% |
Place in category | 2 | 6 | 20 | 2 | 1 | 20 |
% in Category | 2 | 6 | 17 | 2 | 1 | 18 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity 500 Index Institutional Pr | 632.47B | 1.44 | 12.54 | 12.97 | ||
Fidelity Contrafund | 128.94B | 3.52 | 17.24 | 15.17 | ||
Fidelity Contrafund K | 128.94B | 3.55 | 17.32 | 15.27 | ||
Fidelity Total Market Index Instl b | 106.34B | 1.12 | 11.54 | 12.30 | ||
Fidelity Blue Chip Growth | 61.8B | -2.84 | 15.11 | 17.11 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Health Care Adm | 34.63B | 4.15 | 4.94 | 7.02 | ||
Fidelity Select Health Care | 10.35B | 2.50 | 3.68 | 7.60 | ||
T. Rowe Price Health Sciences | 7.37B | 4.25 | 3.25 | 8.01 | ||
Vanguard Health Care Inv | 6.25B | 4.15 | 4.89 | 6.97 | ||
Fidelity Advisor Health Care A | 6.23B | 2.55 | 3.18 | 6.79 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 28.31 | 818.18 | -0.80% | |
Novo Nordisk ADR | US6701002056 | 14.12 | 80.58 | +0.54% | |
AstraZeneca ADR | US0463531089 | 10.24 | 77.23 | -0.18% | |
Merck&Co | US58933Y1055 | 5.07 | 94.32 | -0.50% | |
GSK plc DRC | US37733W2044 | 4.98 | 40.24 | -0.02% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Sell | Strong Buy | Sell |
Summary | Neutral | Strong Buy | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review